Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal
Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.
Read more at The Wall Street Journal
-
Johnson & Johnson makes $15 billion bet on mental-health drugs
Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.MarketWatch - 1d -
H&R Block Coupons and Deals: 15% Off Tax Prep in 2025
When you do your own taxes with the help of H&R Block software (or a human, if you need it), you can get 15% off.Wired - 5d -
Getty Images, Shutterstock to Combine in $3.7 Billion Deal
Getty shareholders will own about 54.7% of the combined company, which will retain the Getty name. Shares of both companies surged on the news.The Wall Street Journal - Jan. 7 -
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.The Wall Street Journal - Jan. 6 -
Johnson secures speakership
It’s a major boon for Republican vows to swiftly implement President-elect Donald Trump’s agenda.Politico - Jan. 3 -
Morning Report — Do or die for Johnson
In today’s issue: Today is Speaker Mike Johnson’s (R-La.) moment of truth. On the first day of the 119th Congress, will his fellow House Republicans let him keep the Speaker’s gavel? Or will ...The Hill - Jan. 3 -
Johnson meets with conservatives as speakership in jeopardy
It's unclear whether House Speaker Mike Johnson has enough support to remain speaker for another term.CBS News - Jan. 2 -
Constellation Inks $1 Billion Nuclear Power Deal
Under the contracts, Constellation will deliver electricity to more than 13 federal agencies.Inc. - Jan. 2 -
Morning Report — Five Johnson holdouts to watch
In today’s issue: What do the holdouts want? What can sway them? Speaker Mike Johnson’s (R-La.) fate rests with a handful of House Republicans who, despite a clear endorsement from ...The Hill - Jan. 1
More from The Wall Street Journal
-
Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs
Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.The Wall Street Journal - 7h -
DirecTV Pursues Sports Fans With New, Slimmer Streaming Bundle
The MySports package includes access to many major sports, but some holes remain.The Wall Street Journal - 7h -
The Hottest Ticket Across Corporate America: Trump's Inauguration
CEOs are angling for invites to parties, which include the MAHA ball and another with Snoop Dogg.The Wall Street Journal - 7h -
Jamie Dimon's Right-Hand Man Announces Retirement at JPMorgan
Piepszak, who’s taking over as COO, has signaled that she doesn’t want to take the top job at the bank, people close to her saidThe Wall Street Journal - 7h -
Google Comes Under U.K. Investigation Over Search Services
It will be the first investigation under a new digital markets competition regime that could force the company to change its conduct.The Wall Street Journal - 7h
More in Business
-
Bond ETFs are down in 2025 ahead of highly anticipated U.S. inflation data
The U.S. bond market is broadly down so far this year, with funds that provide exposure to fixed-income assets hurt by a recent rapid ascent in Treasury yields.MarketWatch - 25m -
Mark Wiedman, a top BlackRock exec thought to be Fink's successor, is leaving the company
Wiedman, head of the global client business, was instrumental in driving BlackRock's growth in passive investing.CNBC - 30m -
This Founder Is Hustling to Turn LA’s Swimming Pools Into Fire Hydrants
As demand triples, Brushfire Battle Systems is scrambling to fill orders.Inc. - 33m -
Microsoft pauses hiring in U.S. consulting unit as part of cost-cutting plan, memo says
Microsoft plans to pause hiring in part of its consulting business in the U.S., according to an internal memo, as the company seeks ways to reel in expenses.CNBC - 40m -
Intel to spin off venture capital arm as chipmaker continues to restructure
Intel said on Tuesday that it plans to spin off Intel Capital, its venture capital wing, into an independent firmCNBC - 43m